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Background
The clavulanic acid (CLV) is nowadays frequently included
in the treatment with Amoxicillin (AX). This component
of the antibiotic therapy initially thought to have a low
immunogenic capacity; however immediate allergic reac-
tions to CLV have been reported in a 30% of patients aller-
gic to AX-CLV. Basophil activation test (BAT) has shown
promising results demonstrating specific recognition of
CLV determinants. The aim of this study was to assess the
value of BAT in the evaluation of immediate allergic reac-
tions to CLV.
Method
Patients with a strong clinical history of having suffered
an immediate reaction after AX-CLV administration
were evaluated. The allergological study followed the
European Academy guidelines, included skin test with
penicillin G, AX, and CLV determinants and drug pro-
vocation test when indicated. BAT was carried out using
AX and CLV at different concentrations (2.5, 1.25, 0.25
and 0.05 mg/ml).
Results
Among 75 patients included, 64 were finally diagnosed as
allergic, 26 to AX and 38 to CLV. The sensitivity of BAT
was 60% and the specificity 81.8%. The inclusion of AX
determinant produced a BAT sensitivity of 54.1% whereas
CLV determinant produced a BAT sensitivity of 78.6%
with a specificity of 91% and 82% respectively. In patients
diagnosed as allergic to AX the BAT sensitivity was 50%
whereas in patients allergic to CLV, BAT sensitivity was
65.8%.
Conclusion
The inclusion of clavulanic acid in the basophil activation
test increases its diagnostic capacity in patients with
immediate allergic reaction to the combination amoxicillin-
clavulanic acid.
Authors’ details
1IBIMA-Regional University Malaga Hospital-UMA, Research Laboratory, Spain.
2IBIMA-Regional University Malaga Hospital-UMA, Allergy Service, Spain.
3Regional University Malaga Hospital, Allergy Service, Spain.
Published: 18 July 2014
doi:10.1186/2045-7022-4-S3-P32
Cite this article as: Fernandez et al.: Inclusion of clavulanic acid
determinants in the basophil activation test improves the evaluation of
immediate reactions to amoxicillin-clavulanic acid. Clinical and Translational
Allergy 2014 4(Suppl 3):P32.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit1IBIMA-Regional University Malaga Hospital-UMA, Research Laboratory, Spain
Full list of author information is available at the end of the article
Fernandez et al. Clinical and Translational Allergy 2014, 4(Suppl 3):P32
http://www.ctajournal.com/content/4/S3/P32
© 2014 Fernandez et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
